Vimarsana
Biggest News Aggregation in the World

Mattek Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mattek Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mattek Life Sciences Today - Breaking & Trending Today

New Jersey Innovation Institute Names Michael Johnson as - Vimarsana News

New Jersey Innovation Institute Names Michael Johnson as

Newark, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- The New Jersey Innovation Institute (NJII), a corporation of New Jersey Institute of Technology (NJIT),...

BICO : MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems - Vimarsana News

BICO : MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems

Boston, MA - June 1, 2023 - Today, MatTek Life Sciences and AIM Biotech announced a strategic partnership through which the AIM Biotech portfolio will be available for sale through... | June 3, 2023

MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems - Vimarsana News

MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems

Today, MatTek Life Sciences and AIM Biotech announced a strategic partnership through which the AIM Biotech portfolio will be available for sale through MatTek.

MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems - Vimarsana News

MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems

MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems

MatTek Life Sciences and NEXT Oncology Announce Licensing Agreement to Develop Lab-Grown Tumors - Vimarsana News

MatTek Life Sciences and NEXT Oncology Announce Licensing Agreement to Develop Lab-Grown Tumors

Ashland, Massachusetts (PRWEB) April 18, 2023 -- [For immediate release: Ashland, MA and San Antonio, TX, April 17, 2023] - MatTek Life Sciences and NEXT

Source: prweb.com